Duke U thinks health AI through

A multidisciplinary innovation team at Duke Health has been asking frontline healthcare workers about their most vexing problems and soliciting their ideas for tech-based solutions since 2014. Most of the proposed visions have involved AI or machine learning.

But coming up with nifty tech tools is only part of the battle to getting them used on the hospital floor. For that the team has brought aboard some unlikely experts.

Take their anthropologist and their sociologist. These colleagues stepped in when, for example, doctors bristled over nurses calling them with alerts from a deep learning sepsis predictor.

Stat News has the story.

“The Duke nurses came up with a range of strategies to deal with this issue, such as timing their calls carefully with physicians’ schedules to make sure they were in a headspace where they would be more receptive to their call,” health-tech writer Erin Brodwin reports.

“At times, they bundled their calls, discussing several patients at once so they wouldn’t be seen as a repeated disruption,” she continues. “But that effort—something [anthropologist Madeleine Clare] Elish and [sociologist Elizabeth Anne] Watkins called ‘repair work’—is difficult and emotional, and it takes another toll on nurses’ well-being.”

Brodwin also looks at a “nutrition facts” idea the innovation team has been noodling with. Its real-world result would be designed to resemble the label you read when buying packaged food, and it would clearly and simply explain how and why to use a given AI tool.

“Duke’s approach is an effort at transparency,” Brodwin notes, “at a time when the vast majority of AI tools remain understudied and often poorly understood among the broader public.”

Read the whole thing.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.